Thus, Zmpste24 knockout (KO) mice have been widely used to investigate the pathogenesis of HGPS and for preclinical testing and therapies (Lai & Wong, 2020). This evidence concerns the gene ZMPSTE24 and Hutchinson-Gilford progeria syndrome.